Nuvis
|
P\S\L Research
|
Home
|
Our News
|
Careers
|
About Us
|
Contact Us
All Industry News by date
mm/dd/yyyy
SUBJECT
11/20/2009
Mutation of influenza A (H1N1) virus sensitive to Tamiflu, Relenza: WHO
-
(Ref. Bloomberg; Easybourse; Forbes; France 24; MarketWatch; The Washington Post; WHO
)
11/20/2009
EMEA backs single doses of GlaxoSmithKline, Novartis H1N1 vaccines
-
(Ref. CNN Money; Forbes; EMEA
)
11/20/2009
Roche reports positive Actemra results from paediatric arthritis study
-
(Ref. Forexyard; Easybourse; Roche
)
11/19/2009
Judge to recommend as many as 6000 Seroquel lawsuits return to home courts
-
(Ref. Bloomberg; Evening Standard
)
11/19/2009
Bayer to appeal NICE's rejection of Nexavar for advanced liver cancer
-
(Ref. BBC News; CNBC; MarketWatch; The Telegraph; The Wall Street Journal; Yahoo!News; NICE; Bayer
)
11/19/2009
Pfizer may enter Japanese generic drug market in 2011
-
(Ref. Forbes; MarketWatch; TheStreet.com
)
11/19/2009
FDA committee supports expanded label for Pfizer, Boehringer Ingelheim's Spiriva
-
(Ref. Forbes; Yahoo!Finance; Pfizer
)
11/19/2009
FDA panel recommends against approval of asthma drug Xolair for children
-
(Ref. Forbes; The Wall Street Journal
)
11/19/2009
AstraZeneca files Brilinta for approval in US
-
(Ref. MSN Money; Forbes; MarketWatch; The Wall Street Journal; AstraZeneca
)
11/19/2009
Retiring Eli Lilly research chief to be given $2-million payout
-
(Ref. The Indianapolis Star; CNN Money
)
11/19/2009
EU committee recommends against use of Merck KGaA's Erbitux in lung cancer
-
(Ref. Forexyard; Merck KGaA
)
11/18/2009
US Senate releases its proposed healthcare reform plan
-
(Ref. Bloomberg; BusinessWeek; Forexpros; MarketWatch; The New York Times; The Washington Post
)
11/18/2009
Lawmakers seek investigation into recent drug pricing trends in the US
-
(Ref. The New York Times; Committee on Energy and Commerce
)
11/18/2009
Differences in Vytorin, Lipitor, simvastatin cardiovascular outcomes not significant: study
-
(Ref. SmartMoney; Bloomberg; The Earth Times
)
11/18/2009
FDA panel gives positive nod to Pfizer's Prevnar 13
-
(Ref. CNN Money; Forbes; The Washington Post; Pfizer
)
11/18/2009
Vivus' erectile-dysfunction drug avanafil meets endpoints in Phase III trial
-
(Ref. MarketWatch; Bloomberg; Forbes; MSN Money; The Indianapolis Star; TheStreet.com; Vivus
)
11/18/2009
Boehringer Ingelheim's dabigatran poses small bleeding risk in ACS patients: study
-
(Ref. Bloomberg; Forexpros; Palm Beach Post
)
11/18/2009
Genzyme to discontinue development of kidney-disease drug
-
(Ref. Forexpros; Xconomy; Morningstar; MSN Money; The Boston Globe; Genzyme
)
11/18/2009
Roche to start new late-stage study for dalcetrapib in atherosclerosis
-
(Ref. Forbes; Roche
)
11/17/2009
FDA warns that Prilosec reduces effectiveness of Plavix
-
(Ref. Bloomberg; MarketWatch; CNN Money; Forbes; Yahoo!Finance; FDA
)
More news
>>>
Privacy Policy
| All contents Copyright© 2009 P\S\L Group. All rights reserved.
